Loading
Diabetes Mellitus, Type 2 / Long limb Roux-en-Y reconstruction after subtotal gastrectomy / Gastric Cancer · Interventional Study
ClinicalTrials.gov · August 7, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an active, prospective multicenter randomized controlled trial registered to compare three surgical reconstruction techniques (Billroth II, conventional Roux-en-Y, and long limb Roux-en-Y) for glycemic control in patients with concurrent type 2 diabetes and gastric cancer. No results have been posted in this registry record, so no efficacy or safety evidence is available for evaluation at this time.
Interventional, Randomized, Parallel, Open label, Treatment purpose. Gastric Cancer, Diabetes Mellitus, Type 2; age from 20 Years; to 69 Years. Intervention: Long limb Roux-en-Y reconstruction; Conventional Roux-en-Y reconstruction; Billroth II reconstruction. Compared with: Billroth II reconstruction after subtotal gastrectomy. n = 120. 1 site: South Korea.
This is an active, prospective multicenter randomized controlled trial registered to compare three surgical reconstruction techniques (Billroth II, conventional Roux-en-Y, and long limb Roux-en-Y) for glycemic control in patients with concurrent type 2 diabetes and gastric cancer. No results have been posted in this registry record, so no efficacy or safety evidence is available for evaluation at this time.
No interim efficacy or safety data provided.
Results from this trial, when available, may inform surgical reconstruction choice in the specific population of diabetic patients undergoing gastric cancer resection. Clinicians should await completion and publication of this trial before applying findings to practice.
This is a registered but actively recruiting trial with no reported results; the study design is sound but outcomes remain unposted in the registry.
As stated by the source record.
Quoted from the source exactly as published.
Results from this trial, when available, may inform surgical reconstruction choice in the specific population of diabetic patients undergoing gastric cancer resection. Clinicians should await completion and publication of this trial before applying findings to practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT04284943). This is a study registration, not published results. Lead sponsor: Korea University Anam Hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 120 participants (ESTIMATED). Conditions: Gastric Cancer, Diabetes Mellitus, Type 2. Interventions: PROCEDURE: Long limb Roux-en-Y reconstruction after subtotal gastrectomy; PROCEDURE: Conventional Roux-en-Y reconstruction after subtotal gastrectomy; PROCEDURE: Billroth II reconstruction after subtotal gastrectomy. Primary outcome measures: The success rate of biochemical improvement of diabetes as measured by HbA1c < 6.5% , 12 months. Brief summary: This is a prospective, multi-center, randomized controlled trial to compare Billroth II reconstruction versus conventional Roux-en-Y reconstruction versus long limb Roux-en-Y reconstruction for glycemic control in patients with concurrent type 2 diabetes and gastric cancer.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.